Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C: a review for primary care physicians.

Tom Wong1, Samuel S Lee

  • 1Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada and the University of Ottawa, Ottawa, Ont. tom_wong@hc-sc.gc.ca

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|March 1, 2006
PubMed
Summary

Many Canadians with chronic hepatitis C virus (HCV) are unaware of their infection, contributing to a hidden epidemic. Early detection and antiviral therapy are crucial for treatment and preventing spread.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulsed Field Ablation With a Variable Loop Circular Catheter in Atrial Fibrillation: Acute Outcomes From the VARIPURE Multicenter Study.

Heart rhythm·2026
Same author

Dendrite initiation and deflection in biaxially stressed solid electrolytes.

Nature·2026
Same author

A Gender-Based Descriptive Analysis of the Canadian Network Undertaking Against Hepatitis C (CANUHC) Cohort From 2015-2023.

Open forum infectious diseases·2026
Same author

Comparative multimodal calibration of patient-specific atrial fibrillation models: Impact of imaging and electrophysiology data on arrhythmogenic substrate identification.

The Journal of physiology·2026
Same author

Leadless pacing comes of age: what the new NICE guidance means for UK practice.

Expert review of cardiovascular therapy·2026
Same author

An interview with Prof. Tom Wong on leadless pacing and NICE guidance in the UK - by Reegan Burnell-Clarke (commissioning editor).

Expert review of cardiovascular therapy·2026

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • An estimated 250,000 Canadians have chronic Hepatitis C Virus (HCV) infection.
  • Approximately one-third of infected individuals are unaware of their status, fueling a significant hidden epidemic.
  • Asymptomatic nature of HCV necessitates risk factor assessment and patient testing.

Purpose of the Study:

  • To highlight the prevalence of undiagnosed chronic Hepatitis C Virus (HCV) in Canada.
  • To emphasize the importance of screening and early diagnosis in primary care settings.
  • To review current diagnostic methods and treatment strategies for HCV.

Main Methods:

  • Review of diagnostic tests including third-generation enzyme immunoassay for HCV antibodies and HCV RNA polymerase chain reaction (PCR) testing.

Related Experiment Videos

  • Discussion of combination therapy with pegylated interferon-alpha and ribavirin.
  • Examination of preventive strategies and counseling recommendations.

    • Main Results:

    • Third-generation enzyme immunoassay is a sensitive and specific test for HCV antibodies.
    • HCV RNA PCR can confirm viral presence in specific cases.
    • Pegylated interferon-alpha and ribavirin therapy achieves viral clearance in 45%-80% of patients, varying by genotype.

    Conclusions:

    • Primary care physicians play a vital role in identifying and managing chronic HCV infections.
    • Increased awareness, risk factor assessment, and timely testing are essential to combat the hidden HCV epidemic.
    • Effective antiviral therapies are available, offering a cure for a significant proportion of infected individuals.